F.D.A. Approves Sickle Cell Treatments, Including One That Uses CRISPR

Posted on AllSides December 8th, 2023
From The Left
Vertex Pharmaceuticals

On Friday, the Food and Drug Administration approved the first gene editing therapy ever to be used in humans, for sickle cell disease, a debilitating blood disorder caused by a single mutated gene.

The agency also approved a second treatment using conventional gene therapy for sickle cell that does not use gene editing.

For the 100,000 Americans with the disease, most of them Black, the approvals offer hope for finally living without an affliction that causes excruciating pain, organ damage and strokes.

Read full story
Some content from this outlet may be limited or behind a paywall.

AllSides Picks

https://www.nytimes.com/2023/12/08/health/fda-sickle-cell-crispr.html

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right